Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Queensland Infant Birth Dose RSV Immunisation Program 2024 - Duration of Protection and Impact

NCT06993753 is registered in ClinicalTrials.gov with Griffith University as lead sponsor.

NCT NCT06993753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06993753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Queensland Infant Birth Dose RSV Immunisation Program 2024 - Duration of Protection and Impact
Lead sponsor
Griffith University
Phase
Observational
Overall status
Active, not recruiting
Start date
April 15, 2024
Completion date
March 31, 2027
Enrollment
4,350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory syncytial viral (rsv) infections